zenocutuzumab
merus
['meru', 'zenocutuzumab', 'merus']
merus presents clinical data on zenocutuzumab (zeno) in nrg1-fusion (nrg1+) cancer at the 2022 american society of clinical oncology (asco) annual meeting (oral abstract) 
EIN Presswire is Everyone's Internet News Presswire™. We make issuing and distributing press releases easy and affordable.